Lipid abnormalities, renal failure, and parathyroid hormone.

Area of Science:

• Nephrology
• Endocrinology
• Metabolic Disorders

Background:

• Chronic renal failure (CRF) is associated with significant metabolic derangements.
• Type IV lipoproteinemia, characterized by elevated very-low-density, intermediate-density, and low-density lipoproteins, is common in CRF patients.
• Existing understanding attributes hypertriglyceridemia in CRF to reduced lipoprotein clearance.

Purpose of the Study:

• To investigate the role of secondary hyperparathyroidism in the pathogenesis of triglyceridemia in chronic renal failure.
• To explore the link between parathyroid hormone (PTH) levels and abnormal carbohydrate and lipid metabolism in CRF.

Main Methods:

• Review of existing data on lipid and carbohydrate metabolism in CRF patients.
• Analysis of findings in parathyroidectomized-normocalcemic dogs with CRF, assessing serum triglyceride, fat tolerance, and lipolytic activity.
• Correlation of PTH levels with metabolic abnormalities.

Main Results:

• CRF patients frequently exhibit type IV lipoproteinemia with normal cholesterol and low high-density lipoprotein levels.
• Hypertriglyceridemia in CRF is linked to decreased activity of lipoprotein lipase and hepatic lipase.
• Parathyroidectomized dogs with CRF showed normalized triglyceride levels, fat tolerance, and lipolytic activity, suggesting a role for PTH.

Conclusions:

• Secondary hyperparathyroidism and elevated PTH levels play a crucial role in the development of hypertriglyceridemia in chronic renal failure.
• Excess PTH suppresses insulin release, leading to carbohydrate intolerance and decreased lipoprotein lipase synthesis, thus causing abnormal lipid metabolism.
• Abnormalities in carbohydrate and lipid metabolism in CRF are interconnected and significantly influenced by hyperparathyroidism.